Companies: 10,795·Total market cap: $144.5T
Flora Growth Corp.

Flora Growth Corp.

FLGCNASDAQHealthcare
$7.79
$-3.69(-32.14%)
Market Cap$4226379
P/E Ratio
52W High$47
52W Low$5.86

Flora Growth Corp. (FLGC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

flgc · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Flora Growth Corp. (FLGC) measures how much investors pay for each dollar of the company's trailing earnings. FLGC's current PE ratio of N/A is calculated by dividing its stock price of $7.79 by its TTM earnings per share of -$15.63.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.65
Based on 1 analyst
EPS (TTM)
-$15.63
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Flora Growth Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Flora Growth Corp.
Flora Growth Corp.You
FLGC
$4MN/A-$15.63
AIM ImmunoTech Inc.
AIM ImmunoTech Inc.
AIM
$2MN/A-$8.62
Akanda Corp.
Akanda Corp.
AKAN
$0MN/A-$245.68
Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc. Common Stock
AMIX
$2MN/A-$0.23
China Pharma Holdings, Inc.
China Pharma Holdings, Inc.
CPHI
$2MN/A-$0.74
Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc.
ENSC
$2MN/A-$3.98
KALA BIO, Inc.
KALA BIO, Inc.
KALA
$50MN/A-$3.31

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$0.00
2024-12-31
FY2024
$-1.30
2023-12-31
FY2023
$-7.75
2022-12-31
FY2022
$-13.68
2021-12-31
FY2021
$-6.49
2020-12-31
FY2020
$-8.08
2019-12-31
FY2019
$-0.65

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Flora Growth Corp. (FLGC) measures how much investors pay for each dollar of the company's trailing earnings. FLGC's current PE ratio of N/A is calculated by dividing its stock price of $7.79 by its TTM earnings per share of -$15.63.

PE Ratio = Stock Price ÷ EPS (TTM)
= $7.79 ÷ -$15.63 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FLGC pe ratio · 6 questions

FLGC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $7.79 and TTM EPS of -$15.63. Data sourced from Financial Modeling Prep via FLGC's SEC 10-K and 10-Q filings.

FLGC PE ratioWhat is FLGC PE ratioCurrent PE ratio of FLGCFLGC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Flora Growth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08